| 前收市價 | 7.16 |
| 開市 | 7.29 |
| 買盤 | 7.26 x 1000 |
| 賣出價 | 7.31 x 900 |
| 今日波幅 | 7.16 - 7.68 |
| 52 週波幅 | 5.61 - 25.66 |
| 成交量 | |
| 平均成交量 | 9,136,073 |
| 市值 | 730.545M |
| Beta 值 (5 年，每月) | 1.68 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -7.11 |
| 業績公佈日 | 2023年11月06日 - 2023年11月10日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 20.60 |
Yahoo FinanceUS approval of fall boosters comes amid uptick in COVID-19 cases
The U.S. Food and Drug Administration (FDA) approved updated COVID-19 booster shots today, setting the stage for a fall vaccine push to combat the still-circulating virus.
InvestorPlace7 Biotech Stocks to Sell in September Before They Crash & Burn
Investing in biotech stocks is not for the meek. Losses can be very large and occur very quickly. In fact, I’ve uncovered seven of the top biotech stocks to sell as we get into the final months of the year. Some of the top ones include: Biotech Stocks to Sell: HOOKIPA Pharma (HOOK) Source: shutterstock.com/Black Salmon HOOKIPA Pharma (NASDAQ:HOOK) is developing a novel platform for therapies aimed at commercializing immunotherapeutics for cancer. After all, such therapies can stimulate an immune
InvestorPlace7 Undervalued Stocks Due for a Massive Short Squeeze
As the market heats up, it’s time to start to look for undervalued short squeeze candidates Citigroup believes that the S&P 500 index has a target of 5,000 in 2024. This is likely considering the point that the U.S. has evaded a recession. Further, monetary policy tightening is almost over. Given the positive outlook, it’s a good time to consider some of the best growth stocks. An important point to note is that when the market sentiment turns bullish, the rally in undervalued short squeeze cand
